Leukemia chemotherapy is believed to be impeded by multidrug resistance (MDR).
INTRODUCTION
Chemotherapy is an important method for the treatment of leukemia, but seldom eradicates the disease. Alternative approaches including molecular targeting therapy, stem cell transplantation and antisense technology are also currently used. However, these therapies are usually complicated, and their effectiveness is even controversial for some cases. In addition, there therapies are very costly.
Multidrug resistance (MDR) is a major cause of failure *Corresponding author. E-mail: qyh1016@sina.com. Tel: +86 04716636691. to chemotherapy in leukemia patients. MDR means leukemia cells resistant to one anti-leukemia drug become resistant to other drugs structurally and are mechanically different from the primary resistant drug. MDR can be primary (primary MDR), or secondary to the administration of an anti-leukemia drug (acquired MDR similar molecular structures, which are present in berries and many other plants. About 6500 kinds of flavonoids have been described to date (Morris and Zhang, 2006) . Based on their chemical structures, they can be classified as 15 subgroups including flavone, flavonol, flavonones, flavanonol, anthocyanidins, flavan-3,4-diols, xanthones, chalcones and biflavonoids, etc (Zhang et al., 2008) . Natural flavonoids have significant pharmacological activities on tumors, cardiovascular system and endocrine system. In vitro studies have found that flavonoids have direct or indirect antitumor actions through interference of cell growth, inhibition of protein kinase activity, induction of apoptosis, suppression of matrix metalloproteinases secretion, and changes of tumor cell invasive behavior (Di Carlo et al., 1999) . The antitumor activities of some flavonoids have also been confirmed in animal models (Mertens-Talcott, 2005) Many studies have revealed that flavonoids, especially flavones and flavonols, exhibit cytotoxicity specifically towards cancer cells through inducing cell cycle arrest and apoptosis (Limtrakul et al., 2007) . Some flavonoids could reverse MDR through increase of intracellular antitumor drug concentration by inhibiting the important drug transporter Pgp on cell membrane (Marilyn and Zhang, 2006; Marks et al., 1992) . Quercetin (Que) and kaempferol (Kae) are flavonoids extracted and separated from Choerospondiatis, a kind of Chinese herbal medicine grown in North China and widely used in cardiovascular disease. Flavonoids are considered to be its effective components. In this study, we applied Que and Kae (Figure 1 ) to the adriamycin-resistant variant human K562/A cells, in order to find out the mechanism of MDR reversion and the targets useful for the management of MDR, we observed the changes of cell growth rate, increase of their sensitivity to adriamycin (ADR), apoptosis, and the expression changes of drug transporter and apoptosis related genes.
MATERIALS AND METHODS

Cell cultures
Human myelogenous leukemia K562 cells and the adriamycinresistant variant K562/A cells (provided by Hematology Laboratory, Peking University First Hospital) were cultured in Iscove's Modified Dulbecco's Medium (IMDM) medium (Hyclone, USA) supplemented with 10% fetal calf serum (Hyclone, USA) at 37°C in a humidified atmosphere of 95% air and 5% CO2. K562/A cells were cultured in a medium containing 1 µg/ml ADR (Main Luck Pharmaceutical, Shenzhen, China), and were grown in drug-free medium for two weeks before the experiments.
Growth rate and ADR sensitivity evaluated by MTT assay K562 or K562/A cells in an amount of 2×10 4 /100 µl/well were cultured in 96-well plates (Corning, USA), and then cultured in a media containing various concentrations of drugs. The inhibition of cell growth rate was evaluated in cells treated with Que, Kae, or Que+Kae (National institute for the Control of Pharmaceutical and Biological Products, China) at the concentrations of 5 to 160 µmol/L. The changes of sensitivity to ADR were tested in cells treated with various concentrations of ADR, in combination with various concentrations of Que, Kae or Que+Kae. The experiments were also performed in cells treated with various concentrations of ADR, verapamil, and ADR+verapamil as test controls. After treatment for 48 h, 10 µl of 5 mg/ml 3-[4,5-dimethylthiazol-2-yl]-2,5 -diphenyltetrazolium bromide (MTT) (Sigma, USA) was added to each well, and the cells were incubated for another 4 h. MTT product was solubilized by addition of 150 µl/well DMSO, and measured at 570 nm using an ELISA reader (Thermo, USA). The experiment was performed in triplicate. IC50 (concentration required for 50% inhibition) was calculated by the Logit method (Michieli et al., 1999) .
Apoptosis determined by annexin V/PI analysis
For apoptosis measurement, K562 and K562/A cells were cultured in media containing various concentrations of Que, Kae, and Que+Kae for 72 h. Apoptosis of treated cells was measured by flow cytometry, using FITC-conjugated annexin V antibody and propidium iodide (KeyGen, China) following the manufacturer's instructions. The experiment was repeated in triplicate.
Gene expression determined by PCR array
K562/A cells were treated with 20 µmol/L Que, Kae, and Que+Kae for 72 h. Total RNA was extracted from the treated cells using TRIZOL Reagent (Invitrogen, USA). Extracted total RNA was further purified by RNeasy MinElute Cleanup Kit (Qiagen, Germany). Its concentration and purity was determined by the NanoDrop ND-1000. Its integrity was checked by electrophoresis in a 1.2% agarose gel, and then it was reverse-transcribed by SuperScript III reverse transcriptase (Invitrogen, USA). The first strand cDNA was diluted and mixed with 2 X SuperArray PCR master mix and water to a total volume of 1100 µl, and the mixture was added to the Human Drug Transporters PCR Array or Apoptosis PCR Array (Superarray, USA). The array was placed in a quantitative real-time PCR instrument (ABI PRISM 7900 system, Applied Biosystems, USA), using a thermal cycle of 95°C for 10 min, 40 cycles of 95°C for 15 s and 60°C for 1 min. The expression difference of a gene was calculated from the difference of the related Ct values.
Statistical analysis
Data was expressed as mean ± SD, and analyzed with student t test by SPSS 17.0 software. P-value below 0.05 was considered as statistically significant. All data points were reported as the mean of triplicates. (Figure 2) . Verapamil in the concentration range of 5 to 20 µmol/L showed no significant inhibition effect on the growth of the two cell lines.
Que and Kae increased the sensitivity of ADR on K562 and K562/A cells
When K562 and K562/A cells were incubated in media containing lower concentration ADR (cell growth inhibition rate <15%), the addition of Que and/or Kae to the media resulted in the increase of their sensitivity to ADR, especially in K562/A cells. Que and/or Kae induced the increase of sensitivity to ADR in K562/A cells at a concentration as low as 10 µmol/L and in a concentration dependent manner. The two compounds had similar effect on the sensitivity to ADR when they were used at lower and moderate concentrations (P >0.05), but Que was more effective than Kae when they were used at higher concentrations (P <0.05). The two compounds had a synergetic effect when both of them were applied to the cells. When the effect of Que and Kae on the sensitivity to ADR was compared with that of verapamil, they were less effective when they were used separately at 10 µmol/L, but were more effective when they were used together even at lower concentrations (5 µmol/L). Therefore, Que and Kae enhanced the antitumor effect of chemotherapeutic agents, especially when they were used together (Table 1) .
Que and Kae induced apoptosis
Both Que and Kae induced apoptosis in K562 and K562/A cells. Apoptosis induced by Que, Kae, and Que+Kae was mainly found to be at early stage, and was in a dosedependent manner. Que and Kae had similar effect on apoptosis of K562 and K562/A cells, and Que+Kae treatment seemed to be more active in inducing apoptosis than Que treatment and Kae treatment alone (Figure 3 ). In addition, verapamil had no apoptosis of the two cell lines, suggesting the different mechanism of MDR reversion between verapamil and the two flavonoids. Cell growth inhibition rate on ordinate was determined from MTT assay data using the formula:
(1-absorbance of experiment group/absorbance of control group) × 100%. Data were presented as mean ± SD of three independent experiments. The Apoptosis PCR array profiles the expression of key genes involved in apoptosis. The array includes TNF ligands and their receptors; members of the Bcl-2 family, caspase, nhibitor of apoptosis (IAP), TNF associatedfactor (TRAF), Caring for Relatives with Dementia (CARD), death domain, death effector domain, and cell death-inducing DNA fragmentation factor-alpha-like effector (CIDE) families; as well as genes involved in p53 and ataxia telangiectasia mutated (ATM) pathways. Que and Kae had different effect on genes related to apoptosis in K562/A cells. For example, Kae regulated the expression of 19 genes in all of the 84 genes on PCR array, but Que regulated only nine genes. Que and Kae down-regulated the expression of genes inhibited apoptosis such as Bcl-2, Bcl-w and up-regulated the expression of genes induced apoptosis such as BAD, and BIM in Bcl-2 family. Both of the flavonoids induced apoptosis though interfering with the balance of TNF and TNFR (Table 2) .
Que and Kae influenced the expression of drug transporter genes
The Human Drug Transporters PCR array contains 84 transporter genes. Transporters play key roles in pharmacological behaviors of drugs, affecting entry and extrusion of drugs in and out of cells. This array includes transporters important to absorption, distribution, metabolism and excretion of many drugs. In addition, transporters such as ABC and SLC gene families which contribute to sensitivity and resistance of tumor cells are also included in this array. Que and Kae regulated some of the genes in ABC transporter family, such as downregulating the famous drug resistance gene ABCB1 (multidrug resistance1). The flavonoids also downregulated the expression of genes relating to chemoresistance in SLC family such as SLC28, SLC29, SLC7 and SLC3 sub-family (Table 3) .
DISCUSSION
Our experiments revealed that the growth of K562 and K562/A cells was inhibited by Que and Kae, especially by Que, in a dose dependent manner, which are similar to the previous results reported by Chen et al. (2005) and Rusak et al. (2005) . An earlier study has also suggested the anti-proliferative activity of Que on normal bone marrow and leukemic progenitors through the interaction with type II estrogen binding sites (Larocca et al., 1991) . We also found that Que and Kae were synergetic with ADR to enhance the antitumor efficiency of ADR, which indicate that Que and Kae have the ability to increase the sensitivity to chemotherapeutic agents such as ADR in addition to the inhibition of tumor cell growth. However, Kae may have specific ability in anti-proliferation. Bestwick et al. (2007) observed that Kae had cytotoxic potentials to HL-60 cells as low concentration as 1 µmol/L, which was probably related to induce cell membrane injury and apoptosis. They also found that Kae inhibited the growth of HL-60 cells at more than 10 µmol/L through changing cell cycles. MDR is a complicated phenomenon related to many processes. Membrane transporters play important roles in mediating chemo-sensitivity and drug resistance of tumor (Huang and Sadée, 2006) . In our real-time PCR array results, most ABC transporters including the famous drug resistance gene ABCB1 were down-regulated, but ABCB4 was up-regulated in K562/A cells after Que and Kae treatment. It may relate to the phenomenon that different transporters mediate different substrates' transportation across cell membrane. For example, some nutrient transporters (glucose, amino acids, organic anions, and peptides) in SLC family may be up-regulated in chemo-resistant tumor cells because of increased energy and nutrition needs. Therefore, down-regulation of many gene members in SLC family by Que and Kae treatment may simply reflect the decreased nutrient uptake due to the growth inhibition of the tumor cells.
The therapeutic activity of many antitumor drugs has been found to rely on the activation of apoptosis pathways in tumor cells, and abnormalities in apoptosis is another important factor leading to multidrug resistance. Our results suggest that Que and Kae induce apoptosis through the expression change of some genes in bcL-2, TNF, and IAP families. However, Que and Kae are different in inducing apoptosis, and they block cell cycles at different phases (Gordana et al., 2005; Bestwick et al., 2007; Kandaswami et al., 2005) . In acute myelocytic leukemia patients, for example, Que induced apoptosis by change of TRAIL signal pathway and caspase-3 expression (Mertens-Talcott, 2005; Kim et al., 2008; Liesveld et al., 2003) . In contrast, Kae was less active than Que in cell growth inhibition and apoptosis, but was a potent reactive oxygen species scavenger in menadionestressed cells (Gordana et al., 2005) . Therefore, Kae may be useful for regulation of immunological function and prevention of diseases.
